Mark Andrews

Tight End

Age: 29
Free Agency: 2026 (UFA)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $16,907,611 (6.69% of cap)
  • 2024 Cash Payout: $11,000,000 (5.40% of spending)
  • 2024 Cash to Cap Ratio: 0.65
  • Contract Value: $56,000,000 ($14,000,000 APY)
  • Fully Guaranteed Money: $30,083,059
  • Contract Ranking: 6/154 at TE

Current Contract

(Extension, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusOther BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
SigningOption
202126$920,000$2,241,776$0$0$0$920,000$3,161,7761.7%
2022 📝
March 20: 2023 salary is guaranteed
27$3,500,000$2,032,611$3,875,000$0$250,000$3,500,000$9,657,6114.7%
202328$7,500,000$2,032,611$3,875,000$0$250,000$7,500,000$13,657,6116.1%
2024 📝
March 18: Roster bonus due
29$7,000,000$2,032,611$3,875,000$4,000,000$0$0$16,907,6116.7%
2025 📝
March 20: Roster bonus due
30$7,000,000$2,032,615$3,875,000$4,000,000$0$0$16,907,6156.5%
Total$25,920,000$10,372,224$15,500,000$8,000,000$500,000$11,920,000$60,292,224

Contract Notes

Mark Andrews signed a four year, $56 million contract with the Ravens on September 6, 2021. Andrews received $37.58 million in guarantees of which $30 million is guaranteed at signing.

Cash Flows

- fully earned money
- unearned or partially earned money
$14M
$28M
$42M
$56M
20212022202320242025
Cash Due$7,500,000$19,250,000$7,500,000$11,000,000$11,000,000
Running Cash$7,250,000$26,500,000$34,000,000$45,000,000$56,000,000
Career Earnings: $40,524,219
Career APY: $6,754,037
Potential Earnings: $62,524,219
Total Guarantees: $30,919,719
Largest Cash Payment: $19,250,000 (2022)
Largest Cap Number: $16,907,615 (2025)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RavensDraftedExtended20184$3,453,160$863,290$836,660$2,691,16077.9%$897,053
RavensExtensionActive20214$56,000,000$14,000,000$30,083,059$37,833,05967.6%$12,611,020
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Ravens6$40,524,219$6,754,037$28,958,9930.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusOption BonusRoster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Ravens$480,000$209,165$0$0$0$0$689,1650.4%$1,316,660
2019Ravens$624,500$209,165$0$0$0$0$833,6650.4%$624,500
2020Ravens$750,000$209,165$0$0$0$0$959,1650.5%$750,000
2021Ravens$920,000$2,241,776$0$0$0$920,000$3,161,7761.7%$11,083,059
2022Ravens$3,500,000$2,032,611$3,875,000$0$250,000$3,500,000$9,657,6114.7%$19,250,000
2023Ravens$7,500,000$2,032,611$3,875,000$0$250,000$7,500,000$13,657,6116.1%$7,500,000
2024Ravens$7,000,000$2,032,611$3,875,000$4,000,000$0$0$16,907,6116.7%$11,000,000
2025Ravens$7,000,000$2,032,615$3,875,000$4,000,000$0$0$16,907,6156.5%$11,000,000
Total$27,774,500$10,999,719$15,500,000$8,000,000$500,000$11,920,000$62,774,219$62,524,219

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2018160034.8%18.2%000.003455216.2300
2019151041.5%18.1%000.006485213.31021
2020140058.1%1.4%000.005870112.1700
2021170075.4%0.0%100.00107136112.7900
2022161177.8%0.5%382.707384711.6500
2023101041.5%0.8%100.004554412.1600

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$6,211,000$14,000,000
Injury Adjusted$6,780,681$13,125,000
test
OTC Valuation $2M $4M $6M $8M $10M APY $2.8M $5.7M $8.5M $11.3M $14.2M $6,604,000 $8,227,624

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.